EurekAlert (press release)New gene therapy corrects a form of inherited macular degeneration in canine modelEurekAlert (press release)Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macul… Continue reading
EurekAlert (press release)New gene therapy corrects a form of inherited macular degeneration in canine modelEurekAlert (press release)Based on success treating other blinding diseases, the group has been developing a gene therapy to treat this conditio… Continue reading
Genetic Engineering & Biotechnology NewsApplications of CRISPR/Cas9 Technology in Translational Research on Solid-Tumor CancersGenetic Engineering & Biotechnology NewsGenome editing has become a powerful tool for biological research and a potential ave… Continue reading
Genetic Engineering & Biotechnology NewsApplications of CRISPR/Cas9 Technology in Translational Research on Solid-Tumor CancersGenetic Engineering & Biotechnology NewsGenome editing has become a powerful tool for biological research and a potential ave… Continue reading
Washington University School of Medicine in St. LouisCRISPR enhances cancer immunotherapyWashington University School of Medicine in St. LouisScientists at Washington University School of Medicine in St. Louis now have used the gene-editing technology … Continue reading
STAT |
After a Few Hiccups, All Bets Are on CRISPR Again – Gizmodo
Gizmodo A letter published in a scientific journal last year challenged the safety of promising gene-editing tool CRISPR, unnerving researchers and investors alike. Now, a smattering of recent studies have redeemed the technology by showing how CRISPR can more … New CRISPR studies show how to limit off-target genome editing – StatSTAT CRISPR’s new tricksHarvard Gazette Crispr gene editing ready for testing in humans – Financial TimesFinancial Times Genetic Engineering & Biotechnology News –BioNews –Genetic Literacy Project all 13 news articles » |
UCLA Newsroom |
UCLA researchers show a cancer defense mechanism could be turned back to attack tumors
UCLA Newsroom “We have generated the first example of a CAR that can help white blood cells — specifically T cells — convert tumor-produced proteins from suppressants, or ‘downers’ for our immune system, into stimulants that trigger robust attacks on the tumor … |